SPONSOR
Universidad de Burgos
Total Trials
2
Recruiting
2
Phases
N/A
Universidad de Burgos is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Old Age; Dementia, Old Age; Debility, Down Syndrome (DS), Supplementation.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Universidad de Burgos
How many clinical trials has Universidad de Burgos sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Universidad de Burgos, of which 2 are actively recruiting participants. These trials cover conditions including Old Age; Dementia, Old Age; Debility, Down Syndrome (DS). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Universidad de Burgos research focus on?
Universidad de Burgos clinical trials span Old Age; Dementia, Old Age; Debility, Down Syndrome (DS), Supplementation. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Universidad de Burgos clinical trial?
To participate in a Universidad de Burgos trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Universidad de Burgos trials with current recruitment status updated daily.
Clinical Trials by Universidad de Burgos
NCT06623864
Recruiting
Significant Activities in the Integrated Person-centered Care Model
Old Age; Dementia
NCT07213063
Recruiting
Effects of Chronic Creatine and Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Oxidative Stress, Inflammation, Muscle Strength, and Body Composition in Individuals With Down Syndrome
Down Syndrome (DS)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology